{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Greenville",
      "state": "NC",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "89397",
      "recalling_firm": "Mayne Pharma Inc",
      "address_1": "1240 Sugg Pkwy",
      "address_2": "N/A",
      "postal_code": "27834-9006",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide within the United States",
      "recall_number": "D-0387-2022",
      "product_description": "Lexette (halobetasol propionate) Topical Foam, 0.05% 50 g canisters, Rx ONLY,  Distributed by: Mayne Pharma Greenville, NC 27834, NDC 51862-604-50",
      "product_quantity": "17,113 canisters",
      "reason_for_recall": "CGMP Deviation: Difficulty dispensing/does not dispense or dispensing liquid instead of foam.",
      "recall_initiation_date": "20220114",
      "center_classification_date": "20220119",
      "report_date": "20220126",
      "code_info": "Lot #: 32451 Exp. 03/2022; 32532 Exp. 04/2022; 32552 Exp. 05/2022; 32701 32733 Exp. 10/2022; 32855 Exp. 02/2023; 32872 Exp. 03/2023."
    }
  ]
}